By Abigail Klein Leichman - April 16, 2018
Originally appeared here in Israel21c
Alzheimer’s disease, affecting some 47 million people worldwide, for now remains an irreversible and fatal brain disorder. Taking a proactive approach, an Israeli brain researcher is developing a vaccine against this devastating disease.
Most vaccines work by mounting an immune response toward a weakened pathogen to boost the immune system’s ability to fight the real pathogen. Prof. Eitan Okun’s vaccine primes the body to attack amyloid beta protein accumulations in the brain, one of the signature signs of Alzheimer’s disease.
Experiments on mice in Okun’s Paul E. Feder Alzheimer’s Research Lab at Bar-Ilan University in Ramat Gan reportedly have shown great promise.
He is now preparing to design human trials on people at known risk of developing the disease in their 50s or younger: those genetically inclined toward Alzheimer’s and people with Down syndrome. Read More